#KO
### ğŸ’Š ëŸ¬ì§€í…ì •(ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼) - íš¨ëŠ¥ ë° íš¨ê³¼
* ì´ ì•½ì€ ê³„ì ˆì„± ë° ë‹¤ë…„ì„± ì•Œë ˆë¥´ê¸°ì„± ë¹„ì—¼, ì•Œë ˆë¥´ê¸°ì„± ê²°ë§‰ì—¼, ë§Œì„± íŠ¹ë°œì„± ë‘ë“œëŸ¬ê¸°, í”¼ë¶€ê°€ë ¤ì›€ì¦ê³¼Â í•˜ì´ë“œë¡œì½”í‹°ì† ì™¸ìš©ì œì™€ ë³‘ìš©ì— ì˜í•œ ìŠµì§„, í”¼ë¶€ì—¼ì— ì‚¬ìš©í•©ë‹ˆë‹¤.

### ğŸ•’ ëŸ¬ì§€í…ì •(ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼) - ìš©ë²• ë° ìš©ëŸ‰
* ì„±ì¸ ë° 6ì„¸ ì´ìƒì˜ ì†Œì•„ëŠ” 1ì¼ 1íšŒ 1ì •(10 mg)ì„ ì·¨ì¹¨ ì „ì— ë³µìš©í•˜ê³ , ì´ìƒë°˜ì‘ì— ë¯¼ê°í•œ í™˜ìì˜ ê²½ìš°ëŠ”Â 1/2ì •(5 mg)ì”©ì„ ì•„ì¹¨, ì €ë…ì— ë¶„í•  ë³µìš©í•©ë‹ˆë‹¤.

ì—°ë ¹, ì¦ìƒì— ë”°ë¼ ì ì ˆíˆ ì¦ê°í•©ë‹ˆë‹¤.

ì‹ ì¥ì•  í™˜ìì˜ íˆ¬ì—¬ ê°„ê²©ì€ í™˜ìì˜ ì‹ ê¸°ëŠ¥ì— ë”°ë¼ ì¡°ì ˆë˜ì–´ì•¼ í•˜ê³ , ì‹ ì¥ì• ë¥¼ ê°€ì§„ ì†Œì•„ í™˜ìëŠ” í™˜ìì˜ ì‹  ì²­ì†Œìœ¨ê³¼ ì²´ì¤‘ì„ ê³ ë ¤í•˜ì—¬ ê°œë³„ì ìœ¼ë¡œ ìš©ëŸ‰ì„ ì¡°ì ˆí•´ì•¼ í•˜ë¯€ë¡œ ìì„¸í•œ ì‚¬í•­ì€ í—ˆê°€ì‚¬í•­ì„ ì°¸ê³ í•˜ì‹­ì‹œì˜¤.

### âš ï¸ ëŸ¬ì§€í…ì •(ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼) - ì£¼ì˜ì‚¬í•­
* ì •ë³´ ì—†ìŒ
* ì´ ì•½ ë°Â íˆë“œë¡ì‹œì§„ ë˜ëŠ” í”¼í˜ë¼ì§„ ìœ ë„ì²´ì— ê³¼ë¯¼ì¦ í™˜ì, ì‹ ë¶€ì „ í™˜ì(í¬ë ˆì•„í‹°ë‹Œ ì²­ì†Œìœ¨ 

ì´ ì•½ì„ ë³µìš©í•˜ê¸° ì „ì— ì„ë¶€, ìˆ˜ìœ ë¶€, ì‹ ì¥ì• (ì‹ ì¥ì¥ì• ), ê°„ì¥ì•  í™˜ì, ë…¸ì¸,Â ê°„ì§ˆ ë° ë°œì‘ ìœ„í—˜ì„±ì´ ìˆëŠ” í™˜ì,Â ì†Œë³€ê³ ì„ì˜ ì„ í–‰ìš”ì¸(ì²™ìˆ˜ ë³‘ë³€, ì „ë¦½ì„  ë¹„ëŒ€ì¦)ì´ ìˆëŠ” í™˜ìëŠ” ì˜ì‚¬ ë˜ëŠ” ì•½ì‚¬ì™€ ìƒì˜í•˜ì‹­ì‹œì˜¤.

#EN
### ğŸ’Š ëŸ¬ì§€í…ì •(ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼) - Indications & Effects
*   This medication is used for seasonal and perennial allergic rhinitis, allergic conjunctivitis, chronic idiopathic urticaria, pruritus, and, in combination with topical hydrocortisone, for eczema and dermatitis.

### ğŸ•’ ëŸ¬ì§€í…ì •(ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼) - Dosage & Administration
*   Adults and children 6 years of age and older should take 1 tablet (10 mg) once daily before bedtime. For patients sensitive to adverse reactions, 1/2 tablet (5 mg) may be taken twice daily, once in the morning and once in the evening.

    The dosage may be appropriately increased or decreased depending on age and symptoms.

    The dosing interval for patients with renal impairment should be adjusted according to their renal function. For pediatric patients with renal impairment, the dosage should be individually adjusted considering the patient's renal clearance and body weight. For detailed information, please refer to the product's approved labeling.

### âš ï¸ ëŸ¬ì§€í…ì •(ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼) - Precautions
*   No information
*   Do not take this medication if you are hypersensitive to this drug, hydroxyzine, or piperazine derivatives, or if you have severe renal failure (creatinine clearance < 10 mL/min).

    Before taking this medication, consult a doctor or pharmacist if you are pregnant, breastfeeding, have renal impairment, hepatic impairment, are elderly, have epilepsy or a risk of seizures, or have predisposing factors for urinary retention (e.g., spinal cord lesion, prostatic hyperplasia).

---

#CN
### ğŸ’Š ëŸ¬ì§€í…ì •(ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼) - åŠŸæ•ˆä¸ä½œç”¨
*   æœ¬è¯ç”¨äºæ²»ç–—å­£èŠ‚æ€§åŠå¸¸å¹´æ€§è¿‡æ•æ€§é¼»ç‚ã€è¿‡æ•æ€§ç»“è†œç‚ã€æ…¢æ€§ç‰¹å‘æ€§è¨éº»ç–¹ã€çš®è‚¤ç˜™ç—’ç—‡ï¼Œå¹¶å¯ä¸æ°¢åŒ–å¯çš„æ¾å¤–ç”¨åˆ¶å‰‚è”ç”¨æ²»ç–—æ¹¿ç–¹ã€çš®ç‚ã€‚

### ğŸ•’ ëŸ¬ì§€í…ì •(ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼) - ç”¨æ³•ç”¨é‡
*   æˆäººåŠ6å²ä»¥ä¸Šå„¿ç«¥ï¼Œæ¯æ—¥1æ¬¡ï¼Œæ¯æ¬¡1ç‰‡ï¼ˆ10 mgï¼‰ï¼Œç¡å‰æœç”¨ã€‚å¯¹äºå¯¹ä¸è‰¯ååº”æ•æ„Ÿçš„æ‚£è€…ï¼Œå¯å°†1/2ç‰‡ï¼ˆ5 mgï¼‰åˆ†æ—©æ™šä¸¤æ¬¡æœç”¨ã€‚

    æ ¹æ®å¹´é¾„ã€ç—‡çŠ¶å¯é€‚å½“å¢å‡å‰‚é‡ã€‚

    è‚¾åŠŸèƒ½ä¸å…¨æ‚£è€…çš„ç»™è¯é—´éš”åº”æ ¹æ®å…¶è‚¾åŠŸèƒ½è¿›è¡Œè°ƒæ•´ã€‚æ‚£æœ‰è‚¾åŠŸèƒ½ä¸å…¨çš„å„¿ç«¥æ‚£è€…ï¼Œåº”æ ¹æ®æ‚£è€…çš„è‚¾æ¸…é™¤ç‡å’Œä½“é‡ä¸ªä½“åŒ–è°ƒæ•´å‰‚é‡ï¼Œè¯¦æƒ…è¯·å‚è€ƒæ‰¹å‡†è¯´æ˜ä¹¦ã€‚

### âš ï¸ ëŸ¬ì§€í…ì •(ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼) - æ³¨æ„äº‹é¡¹
*   æ— ä¿¡æ¯
*   å¯¹æœ¬è¯ã€ç¾Ÿå—ªæˆ–å“Œå—ªè¡ç”Ÿç‰©è¿‡æ•çš„æ‚£è€…ï¼Œä»¥åŠè‚¾åŠŸèƒ½ä¸å…¨æ‚£è€…ï¼ˆè‚Œé…æ¸…é™¤ç‡ < 10 mL/minï¼‰ç¦ç”¨æœ¬è¯ã€‚

    æœç”¨æœ¬è¯å‰ï¼Œå­•å¦‡ã€å“ºä¹³æœŸå¦‡å¥³ã€è‚¾åŠŸèƒ½ä¸å…¨æ‚£è€…ã€è‚åŠŸèƒ½ä¸å…¨æ‚£è€…ã€è€å¹´äººã€æœ‰ç™«ç—«åŠæƒŠå¥é£é™©çš„æ‚£è€…ã€æœ‰å°¿æ½´ç•™å…ˆå†³æ¡ä»¶ï¼ˆè„Šé«“ç—…å˜ã€å‰åˆ—è…ºå¢ç”Ÿï¼‰çš„æ‚£è€…ï¼Œè¯·å’¨è¯¢åŒ»ç”Ÿæˆ–è¯å¸ˆã€‚

---

#JP
### ğŸ’Š ëŸ¬ì§€í…ì •(ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼) - åŠ¹èƒ½ãƒ»åŠ¹æœ
*   ã“ã®è–¬ã¯ã€å­£ç¯€æ€§åŠã³é€šå¹´æ€§ã‚¢ãƒ¬ãƒ«ã‚®ãƒ¼æ€§é¼»ç‚ã€ã‚¢ãƒ¬ãƒ«ã‚®ãƒ¼æ€§çµè†œç‚ã€æ…¢æ€§ç‰¹ç™ºæ€§è•éº»ç–¹ã€çš®è†šæ»ç—’ç—‡ã€ãªã‚‰ã³ã«ãƒ’ãƒ‰ãƒ­ã‚³ãƒ«ãƒã‚¾ãƒ³å¤–ç”¨å‰¤ã¨ã®ä½µç”¨ã«ã‚ˆã‚‹æ¹¿ç–¹ã€çš®è†šç‚ã«ç”¨ã„ã‚‰ã‚Œã¾ã™ã€‚

### ğŸ•’ ëŸ¬ì§€í…ì •(ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼) - ç”¨æ³•ãƒ»ç”¨é‡
*   æˆäººåŠã³6æ­³ä»¥ä¸Šã®å°å…ã¯ã€1æ—¥1å›1éŒ ï¼ˆ10 mgï¼‰ã‚’å°±å¯å‰ã«æœç”¨ã—ã¾ã™ã€‚å‰¯ä½œç”¨ã«æ•æ„Ÿãªæ‚£è€…ã®å ´åˆã¯ã€1/2éŒ ï¼ˆ5 mgï¼‰ã‚’æœã¨å¤•ã«åˆ†å‰²ã—ã¦æœç”¨ã—ã¾ã™ã€‚

    å¹´é½¢ã€ç—‡çŠ¶ã«ã‚ˆã‚Šé©å®œå¢—æ¸›ã—ã¾ã™ã€‚

    è…æ©Ÿèƒ½éšœå®³æ‚£è€…ã®æŠ•ä¸é–“éš”ã¯ã€æ‚£è€…ã®è…æ©Ÿèƒ½ã«å¿œã˜ã¦èª¿æ•´ã™ã‚‹å¿…è¦ãŒã‚ã‚Šã¾ã™ã€‚è…æ©Ÿèƒ½éšœå®³ã®ã‚ã‚‹å°å…æ‚£è€…ã®å ´åˆã€æ‚£è€…ã®è…ã‚¯ãƒªã‚¢ãƒ©ãƒ³ã‚¹ã¨ä½“é‡ã‚’è€ƒæ…®ã—ã¦å€‹åˆ¥ã«ç”¨é‡ã‚’èª¿æ•´ã™ã‚‹å¿…è¦ãŒã‚ã‚‹ãŸã‚ã€è©³ç´°ã«ã¤ã„ã¦ã¯æ·»ä»˜æ–‡æ›¸ã‚’å‚ç…§ã—ã¦ãã ã•ã„ã€‚

### âš ï¸ ëŸ¬ì§€í…ì •(ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼) - æ³¨æ„äº‹é …
*   æƒ…å ±ãªã—
*   æœ¬å‰¤åŠã³ãƒ’ãƒ‰ãƒ­ã‚­ã‚·ã‚¸ãƒ³ã¾ãŸã¯ãƒ”ãƒšãƒ©ã‚¸ãƒ³èª˜å°ä½“ã«éæ•ç—‡ã®æ‚£è€…ã€è…ä¸å…¨æ‚£è€…ï¼ˆã‚¯ãƒ¬ã‚¢ãƒãƒ‹ãƒ³ã‚¯ãƒªã‚¢ãƒ©ãƒ³ã‚¹ < 10 mL/minï¼‰ã¯æœç”¨ã—ãªã„ã§ãã ã•ã„ã€‚

    ã“ã®è–¬ã‚’æœç”¨ã™ã‚‹å‰ã«ã€å¦Šå©¦ã€æˆä¹³å©¦ã€è…æ©Ÿèƒ½éšœå®³ï¼ˆè…è‡“éšœå®³ï¼‰ã€è‚æ©Ÿèƒ½éšœå®³æ‚£è€…ã€é«˜é½¢è€…ã€ã¦ã‚“ã‹ã‚“ãŠã‚ˆã³ç™ºä½œã®ãƒªã‚¹ã‚¯ãŒã‚ã‚‹æ‚£è€…ã€å°¿é–‰ã®ç´ å› ï¼ˆè„Šé«„ç—…å¤‰ã€å‰ç«‹è…ºè‚¥å¤§ç—‡ï¼‰ãŒã‚ã‚‹æ‚£è€…ã¯ã€åŒ»å¸«ã¾ãŸã¯è–¬å‰¤å¸«ã«ã”ç›¸è«‡ãã ã•ã„ã€‚